Clinical Trials on Subjects With Moderate to Severe, Chronic Nonmalignant Pain
Total 88 results
-
Mundipharma Research GmbH & Co KGCompletedSubjects With Moderate to Severe, Chronic Nonmalignant Pain
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
Nektar TherapeuticsTerminatedModerate to Severe Chronic PainUnited States
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
Janssen PharmaceuticaWithdrawnModerate to Severe Chronic Non-cancer Pain
-
PfizerCompleted
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
QRxPharma Inc.CompletedAcute Moderate to Severe PainUnited States
-
Janssen PharmaceuticaWithdrawnModerate to Severe Acute Non-Cancer Pain
-
AcelRx Pharmaceuticals, Inc.CompletedModerate-to-severe Acute PainUnited States
-
AcelRx Pharmaceuticals, Inc.U.S. Army Medical Research and Development CommandCompletedModerate-to-severe Acute PainUnited States
-
Mundipharma Research GmbH & Co KGCompletedModerate to Severe Idiopathic RLS With Daytime SymptomsSpain, Sweden, Germany
-
Tris Pharma, Inc.Forest LaboratoriesCompletedModerate to Severe Chronic Pain Due to Osteoarthritis of the KneeUnited States
-
KLOX Technologies Inc.CompletedModerate to Severe Chronic PeriodontitisCanada
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisChina
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Canada
-
QRxPharma Inc.CompletedModerate to Severe Postoperative PainUnited States
-
Organon and CoTerminatedModerate to Severe Primary Dysmenorrhea
-
Dong-A ST Co., Ltd.Meiji Seika Pharma Co., Ltd.CompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingModerate to Severe Chronic Plaque PsoriasisChina
-
Sun Pharmaceutical Industries LimitedRecruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain
-
Novartis PharmaceuticalsActive, not recruitingModerate to Severe Chronic Plaque PsoriasisChina
-
AbbVie (prior sponsor, Abbott)IMS HealthCompletedModerate-to-severe Chronic Plaque Psoriasis
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical TrialsCompletedModerate to Severe Acute Lower Back PainUnited States
-
CelltrionRecruitingModerate to Severe Chronic Plaque PsoriasisEstonia
-
Biocon Biologics UK LtdActive, not recruitingModerate to Severe Chronic Plaque PsoriasisUnited States
-
Astellas Pharma IncBiogenCompleted
-
AcelRx Pharmaceuticals, Inc.CompletedAcute Moderate-to-severe PainUnited States
-
Grünenthal GmbHDepomedTerminatedModerate to Severe Acute Postoperative PainUnited States, United Kingdom, Poland
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Novartis PharmaceuticalsCompletedPatients With Moderate-to-severe COPD With Destroyed Lung by TuberculosisKorea, Republic of
-
FemmePharma Global Healthcare, Inc.CompletedModerate to Severe Cyclic MastalgiaUnited States
-
Bracco Diagnostics, IncCompleted
-
AbbVie (prior sponsor, Abbott)WithdrawnModerate to Severe Chronic Plaque Psoriasis
-
Lindner Center of HOPEUniversity of Cincinnati; AbbottCompletedBipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild ManiaUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
Jazz PharmaceuticalsCompletedPatients With Severe Chronic PainUnited States
-
RadiancyCompletedMild to Moderate Chronic Low Back PainIsrael
-
Meir Medical CenterUnknownHealthy Subjects | Moderate to Severe Keratoconjunctivitis Sicca (KCS) | Dry Eye Syndrome (DES)
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingModerate to Severe Acute PainChina